scholarly article | Q13442814 |
P50 | author | Scott A. Przybelski | Q114336657 |
Timothy G Lesnick | Q114336660 | ||
Clifford Jack | Q30505709 | ||
Glenn E. Smith | Q46205917 | ||
Ronald C. Petersen | Q56839853 | ||
David S Knopman | Q63967707 | ||
Bradley F Boeve | Q67501037 | ||
Kejal Kantarci | Q83230766 | ||
Tanis J Ferman | Q91521563 | ||
P2093 | author name string | Walter K Kremers | |
P2860 | cites work | Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 |
Mild cognitive impairment: clinical characterization and outcome | Q28140626 | ||
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29547554 | ||
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q29614406 | ||
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium | Q29614409 | ||
Mild cognitive impairment as a diagnostic entity | Q29619568 | ||
The neuropathology of probable Alzheimer disease and mild cognitive impairment | Q33616561 | ||
Mild cognitive impairment associated with limbic and neocortical Lewy body disease: a clinicopathological study | Q33656306 | ||
Low sensitivity in clinical diagnoses of dementia with Lewy bodies | Q33729642 | ||
Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease | Q33937968 | ||
Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies | Q34384006 | ||
Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies | Q34715043 | ||
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop | Q34736093 | ||
Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study | Q35219292 | ||
Clinical characterization of mild cognitive impairment as a prodrome to dementia with Lewy bodies | Q36121420 | ||
Focal atrophy on MRI and neuropathologic classification of dementia with Lewy bodies | Q36146930 | ||
Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study | Q36374857 | ||
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease | Q36650399 | ||
Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in a community-based sample | Q36774991 | ||
MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies | Q37265436 | ||
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment | Q37313709 | ||
Hippocampal volumes, proton magnetic resonance spectroscopy metabolites, and cerebrovascular disease in mild cognitive impairment subtypes | Q37345411 | ||
Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study. | Q38425164 | ||
Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia | Q48550309 | ||
DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging | Q48604179 | ||
Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. | Q51947204 | ||
Atypical and typical presentations of Alzheimer's disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases. | Q53233338 | ||
Neuropathological correlates of volumetric MRI in autopsy-confirmed Lewy body dementia | Q57813517 | ||
P433 | issue | 22 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dementia | Q83030 |
mild cognitive impairment | Q1472703 | ||
dementia with Lewy bodies | Q101245788 | ||
P304 | page(s) | 2317-2323 | |
P577 | publication date | 2016-11-02 | |
P1433 | published in | Neurology | Q1161692 |
P1476 | title | Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment | |
P478 | volume | 87 |
Q64071876 | Cortical Gray Matter and Hippocampal Atrophy in Idiopathic Rapid Eye Movement Sleep Behavior Disorder |
Q90397753 | Differentiation Between Dementia With Lewy Bodies And Alzheimer's Disease Using Voxel-Based Morphometry Of Structural MRI: A Multicenter Study |
Q92587499 | Effect Modifiers of TDP-43-Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes |
Q91325509 | Imaging in prodromal dementia with Lewy bodies: Where do we stand? |
Q55218352 | Neurocognitive Profiles of Older Adults with Working-Memory Dysfunction. |
Q64280765 | Pharmacological Management of Dementia with Lewy Bodies |
Q89670961 | Prodromal Dementia with Lewy Bodies: Clinical Characterization and Predictors of Progression |
Q91931101 | REM sleep atonia loss distinguishes synucleinopathy in older adults with cognitive impairment |
Q92552329 | Tau is required for progressive synaptic and memory deficits in a transgenic mouse model of α-synucleinopathy |
Q64814715 | The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders. |
Search more.